ArticleCase reports in transplantation2026
Spindle Cell Sarcoma of the Abdominal Aorta Following Endovascular Aneurysm Repair in a Kidney Transplant Recipient.
Article in Case reports in transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Spindle Cell Sarcoma of the Abdominal Aorta Following Endovascular Aneurysm Repair in a Kidney Transplant Recipient.Case reports in transplantation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A kidney transplant recipient developed spindle cell sarcoma within an abdominal aortic aneurysm following prior endovascular aneurysm repair (EVAR). The patient had undergone EVAR for abdominal aortic aneurysm before successful living-donor kidney transplantation and maintained stable graft function under immunosuppressive therapy. Two years after transplantation, he presented with back pain, elevated inflammatory marker, and aneurysm enlargement, initially suspected as an infected aneurysm. Despite antibiotic therapy, the lesion progressed. Positron emission tomography demonstrated increased fluorodeoxyglucose uptake, and computed tomography-guided biopsy revealed undifferentiated spindle cell sarcoma with unclear lineage differentiation. Surgical resection was not feasible, and systemic chemotherapy was initiated; however, disease progression continued, and the patient died 7 months after admission. Aortic sarcoma following EVAR is rare and may mimic infection or inflammatory complications. Clinicians should consider malignant etiologies when transplant recipients with prior EVAR present with atypical aneurysm enlargement or persistent inflammatory findings, and early tissue diagnosis may be necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.